Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Pani, A."'
Publikováno v:
In European Journal of Pharmacology 2009 620(1):36-41
Autor:
Marchese, Giorgio, Ruiu, Stefania, Casti, Paola, Bartholini, Francesco, Saba, Pierluigi, Gessa, Gian Luigi, Pani, Luca *
Publikováno v:
In European Journal of Pharmacology 2002 447(1):109-114
Autor:
Marchese, Giorgio, Bartholini, Francesco, Ruiu, Stefania, Casti, Paola, Saba, Pierluigi, Gessa, Gian Luigi, Pani, Luca *
Publikováno v:
In European Journal of Pharmacology 2002 444(1):69-74
Publikováno v:
In European Journal of Pharmacology 2001 432(2):143-147
Autor:
Maria Antonietta Casu, Giorgio Marchese, Mauro A.M. Carai, Gian Luigi Gessa, Pierluigi Saba, Roberta Reali, Stefania Ruiu, Anna Porcella, Luca Pani
Publikováno v:
European Journal of Pharmacology. 459:97-105
Recently, the gastrointestinal pharmacology of cannabinoid CB(1) receptors has been extensively explored. We employed western blotting and immunohistochemistry techniques to study the distribution of the cannabinoid CB(1) receptor protein in the mous
Publikováno v:
European Journal of Pharmacology. 432:143-147
Amisulpride is a substituted benzamide antipsychotic with nanomolar affinity and high selectivity for dopamine D(2) and dopamine D(3) receptors. The interaction of racemic (+/-)RS amisulpride and its two enantiomers (+)R and (-)S with dopamine D(2) a
Publikováno v:
European Journal of Pharmacology. 262:107-111
We compared the effect of two selective dopamine D 1 receptor agonists, SKF 38393 ((±)-1-phenyl-2,3,4,5-tetrahydro-(1 H )- 3-benzazepine-7,8-diol · HCl) and A68930 ((1 R ,3 S )-1-aminomethyl-5,6-dihydroxy-3-phenylisochroman · HCl), and that of imi
Autor:
Stefania Ruiu, Giorgio Marchese, Luca Pani, Angela Sanna, Gabriele Pinna Spada, Paola Casti, Gianluca Casu
Publikováno v:
European journal of pharmacology 598 (2008): 16–20. doi:10.1016/j.ejphar.2008.08.020
info:cnr-pdr/source/autori:Marchese G a,b; Sanna A b; Casu G b; Casti P b; Spada GP b; Ruiu S a,b; Pani L a,b/titolo:Delta-9-tetrahydrocannabinol differently affects striatal c-Fos expression following haloperidol or clozapine administration./doi:10.1016%2Fj.ejphar.2008.08.020/rivista:European journal of pharmacology/anno:2008/pagina_da:16/pagina_a:20/intervallo_pagine:16–20/volume:598
info:cnr-pdr/source/autori:Marchese G a,b; Sanna A b; Casu G b; Casti P b; Spada GP b; Ruiu S a,b; Pani L a,b/titolo:Delta-9-tetrahydrocannabinol differently affects striatal c-Fos expression following haloperidol or clozapine administration./doi:10.1016%2Fj.ejphar.2008.08.020/rivista:European journal of pharmacology/anno:2008/pagina_da:16/pagina_a:20/intervallo_pagine:16–20/volume:598
It was previously shown that haloperidol, but not clozapine, induced intense rat catalepsy when co-administered with delta-9-tetrahydrocannabinol. The present study investigated whether similar alterations could be observed on striatal c-Fos immunore
Publikováno v:
European Journal of Pharmacology. 190:217-221
The effect of different calcium antagonists on cocaine-induced dopamine (DA) release in the striatum, as measured by brain microdialysis in freely moving rats, and on cocaine-induced motor stimulation was studied. While two dihydropyridine calcium an
Publikováno v:
European journal of pharmacology. 504(1-2)
Quetiapine is a novel atypical antipsychotic drug with multi-receptorial affinity. Using in vivo microdialysis, we investigated if quetiapine modulates extracellular noradrenaline and dopamine in brain areas generally believed to be involved in the p